Cargando…

A Novel, Circulating Tumor Cell Enrichment Method Reduces ARv7 False Positivity in Patients with Castration-Resistant Prostate Cancer

Background: The AR-V7 splice variant is a cause of castration-resistant prostate cancer (CRPC). However, testing for the presence of AR-V7 by real-time polymerase chain reaction (RT-PCR) shows AR-V7 positivity in healthy individuals. We hypothesized that the positivity reflects contamination by hema...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakasato, Takehiko, Kusaka, Chiho, Ota, Mika, Hasebe, Yuki, Ueda, Kumiko, Unoki, Tsutomu, Oshinomi, Kazuhiko, Morita, Jun, Maeda, Yoshiko, Shichijo, Takeshi, Naoe, Michio, Ogawa, Yoshio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151149/ https://www.ncbi.nlm.nih.gov/pubmed/32168745 http://dx.doi.org/10.3390/diagnostics10030151

Ejemplares similares

Development of a Highly Sensitive Technique for Capturing Renal Cell Cancer Circulating Tumor Cells
por: Naoe, Michio, et al.
Publicado: (2019)

Lung adenocarcinoma diagnosed incidentally after renal biopsy for suspected right renal cancer
por: Nepal, Sat Prasad, et al.
Publicado: (2021)

MRI-guided conservative management of a left segmental testicular infarction
por: Nepal, Sat Prasad, et al.
Publicado: (2021)

Surgical challenges of Castleman's disease of the pelvis
por: Nepal, Sat Prasad, et al.
Publicado: (2020)

Impalement Injury of the Urinary Bladder: A Case Report
por: Morita, Jun, et al.
Publicado: (2012)

Hard bilateral syphilitic testes with vasculitis: a case report and literature review
por: Nepal, Sat Prasad, et al.
Publicado: (2021)

Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios alone or combined with prostate-specific antigen for the diagnosis of prostate cancer and clinically significant prostate cancer
por: Nepal, Sat Prasad, et al.
Publicado: (2023)

A case of complete response following the administration of pembrolizumab and metastasectomy for lung and bone metastases of bladder cancer
por: Nakasato, Takehiko, et al.
Publicado: (2021)

New ARV drugs
por: Gulick, Roy
Publicado: (2014)

Development of long-acting ARV’s
por: Boffito, Marta
Publicado: (2014)

ARV regimen choice and co-morbidities
por: Peters, Barry
Publicado: (2014)

Perineal recurrence of prostate ductal adenocarcinoma after transperineal brachytherapy: a case report and literature review
por: Fukagai, Takashi, et al.
Publicado: (2020)

Accumulated precursors of specific GPI-anchored proteins upregulate GPI biosynthesis with ARV1
por: Liu, Yi-Shi, et al.
Publicado: (2023)

Women and ARV-based prevention: opportunities and challenges
por: Geary, Cynthia W, et al.
Publicado: (2014)

Prevention of mother-to-child transmission of HIV in Zambia: implementing efficacious ARV regimens in primary health centers
por: Mandala, Justin, et al.
Publicado: (2009)

Patent Pools for ARVs: Industry Perspectives from ASPEN
por: Nicolaou, Stavros
Publicado: (2010)

Women and ARV-based HIV prevention – challenges and opportunities
por: Geary, Cynthia W, et al.
Publicado: (2014)

Environmental Risk Characterization of an Antiretroviral (ARV) Lamivudine in Ecosystems
por: Omotola, Elizabeth Oyinkansola, et al.
Publicado: (2021)

Analysis of AR/ARV7 Expression in Isolated Circulating Tumor Cells of Patients with Metastatic Castration-Resistant Prostate Cancer (SAKK 08/14 IMPROVE Trial)
por: Bratic Hench, Ivana, et al.
Publicado: (2019)

Recombinant Newcastle Disease Virus (NDV) Expressing Sigma C Protein of Avian Reovirus (ARV) Protects against Both ARV and NDV in Chickens
por: Saikia, Deep Prakash, et al.
Publicado: (2019)

Could Circulating Tumor Cells and ARV7 Detection Improve Clinical Decisions in Metastatic Castration-Resistant Prostate Cancer? The Istituto Nazionale dei Tumori (INT) Experience
por: Sepe, Pierangela, et al.
Publicado: (2019)

ARV formulated microbicides big promise; as world waits vaccine
por: Ondari, Ronald Orutwa, et al.
Publicado: (2009)

The clinic-biological progress of patients on ARV under D.O.T
por: Lyli, O, et al.
Publicado: (2009)

ARV-based HIV prevention for women – where we are in 2014
por: Mastro, Timothy D, et al.
Publicado: (2014)

Strategies to reduce risks in ARV supply chains in the developing world
por: Larson, Chris, et al.
Publicado: (2014)

Dual Therapy Treatment Strategies for the Management of Patients Infected with HIV: A Systematic Review of Current Evidence in ARV-Naive or ARV-Experienced, Virologically Suppressed Patients
por: Baril, Jean-Guy, et al.
Publicado: (2016)

Significance of FDG-PET in Identification of Diseases of the Appendix – Based on Experience of Two Cases Falsely Positive for FDG Accumulation
por: Ogawa, Shimpei, et al.
Publicado: (2009)

The ARV roll out and the disability grant: a South African dilemma?
por: de Paoli, Marina Manuela, et al.
Publicado: (2012)

Designing ARVs Patent Pool Up to Trade & Policy Evolutionary Dynamics
por: Dionisio, Daniele, et al.
Publicado: (2010)

Pooling ARV Drug Patents: A Pro-Access Fitting Strategy?
por: Dionisio, Daniele
Publicado: (2010)

Biomarkers and biometric measures of adherence to use of ARV-based vaginal rings
por: Stalter, Randy M, et al.
Publicado: (2016)

Occurrence of Reovirus (ARV) Infections in Poultry Flocks in Poland in 2010–2017
por: Czekaj, Hanna, et al.
Publicado: (2018)

Migrating Focal Seizures and Myoclonic Status in ARV1-Related Encephalopathy
por: Darra, Francesca, et al.
Publicado: (2021)

Surveillance of ARV safety in pregnancy and breastfeeding: towards a new framework
por: Renaud, Françoise, et al.
Publicado: (2022)

Consistency between clinician and patient perspectives on ARV treatment commencement and switching examined
por: Grierson, Jeffrey, et al.
Publicado: (2012)

ARVs: The Next Generation. Going Boldly Together to New Frontiers of HIV Treatment
por: Barnhart, Matthew, et al.
Publicado: (2015)

Disclosing in utero HIV/ARV exposure to the HIV-exposed uninfected adolescent: is it necessary?
por: Jao, Jennifer, et al.
Publicado: (2016)

IL-1RN and IL-1β Polymorphism and ARV-Associated Hepatotoxicity
por: Singh, HariOm, et al.
Publicado: (2018)

Resveratrol enhances polyubiquitination-mediated ARV7 degradation in prostate cancer cells
por: Wilson, Sarah, et al.
Publicado: (2017)

COVID-19 pandemic and antiretrovirals (ARV) availability in Nigeria: recommendations to prevent shortages
por: Dada, David Adelekan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_eurmh89mbdr157eov16t14sl3j